Literature DB >> 15619091

Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters.

Sittisak Honsawek1, Voranush Chongsrisawat, Paisarn Vejchapipat, Nutchanart Thawornsuk, Pisit Tangkijvanich, Yong Poovorawan.   

Abstract

Biliary atresia (BA) is a neonatal obliterative cholangiopathy of unknown etiology. Despite the Kasai procedure, hepatic fibrosis and portal hypertension (PH) still occur. Interleukin-8 (IL-8) is an important mediator of inflammation and immune response in human disease. The objective of this study was to investigate the potential role of IL-8 in the pathogenesis of the progressive, sclerosing, inflammatory process and fibrosis in BA. A total of 60 pediatric patients with BA and 15 healthy children were evaluated. The mean ages of BA patients and controls were 6.3 +/- 0.6 and 6.7 +/- 1.1 years, respectively. The patients were classified into two groups according to their clinical outcomes: patients with jaundice (total bilirubin +/- 25.5 micromol/l) and patients without jaundice (total bilirubin < 25.5 micromol/l). The IL-8 levels in serum samples were determined by commercially available enzyme-linked immunosorbent assay. Serum IL-8 levels were higher in the BA patients than in healthy children (236.2 +/- 60.1 vs. 34.5 +/- 12.1 pg/ml, P < 0.001). Patients with jaundice had lower levels of albumin but had greater levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and gamma glutamyl transpeptidase compared with patients without jaundice. Serum IL-8 levels in the jaundice group were significantly higher than in those without jaundice (516.5 +/- 130.0 vs. 49.3 +/- 10.4 pg/ml, P < 0.0005). Furthermore, patients with PH had higher IL-8 levels than those without PH (378.1 +/- 102.2 vs. 106.6 +/- 48.4 pg/ml, P < 0.005). In the jaundice-free group, IL-8 levels were elevated in patients with PH compared with those without PH (79.0 +/- 17.4 vs. 19.7 +/- 5.8 pg/ml, P < 0.005). The present study demonstrated elevation of serum IL-8 levels in children with BA. Serum IL-8 levels were also higher in patients with jaundice compared with patients without jaundice. These findings suggest that IL-8 may play a significant role in the pathogenesis of BA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15619091     DOI: 10.1007/s00383-004-1329-x

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  28 in total

Review 1.  Mechanisms of hepatotoxicity.

Authors:  Hartmut Jaeschke; Gregory J Gores; Arthur I Cederbaum; Jack A Hinson; Dominique Pessayre; John J Lemasters
Journal:  Toxicol Sci       Date:  2002-02       Impact factor: 4.849

2.  Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents.

Authors:  L P James; H C Farrar; T L Darville; J E Sullivan; T G Givens; G L Kearns; G S Wasserman; P M Simpson; J A Hinson
Journal:  Clin Pharmacol Ther       Date:  2001-09       Impact factor: 6.875

Review 3.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

Authors:  M Baggiolini; B Dewald; B Moser
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

4.  Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Authors:  F M Brennan; C O Zachariae; D Chantry; C G Larsen; M Turner; R N Maini; K Matsushima; M Feldmann
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

5.  Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes.

Authors:  A J Thornton; R M Strieter; I Lindley; M Baggiolini; S L Kunkel
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

6.  Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups.

Authors:  S C Donnelly; R M Strieter; S L Kunkel; A Walz; C R Robertson; D C Carter; I S Grant; A J Pollok; C Haslett
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

Review 7.  Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration.

Authors:  A Rot
Journal:  Immunol Today       Date:  1992-08

8.  Calculation of biliary atresia prognostic index using a multivariate linear model.

Authors:  M Endo; H Masuyama; K Watanabe; K Hagane; H Ikawa; J Yokoyama; M Kitajima
Journal:  J Pediatr Surg       Date:  1995-11       Impact factor: 2.545

9.  Interleukin-8 and granulocyte-macrophage colony-stimulating factor secretion in hepatocellular carcinoma and viral chronic active hepatitis.

Authors:  A al-Wabel; B al-Knawy; S Raziuddin
Journal:  Clin Immunol Immunopathol       Date:  1995-03

10.  The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.

Authors:  J M Schröder
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  5 in total

1.  High serum matrix metalloproteinase-3 and liver stiffness in postoperative biliary atresia.

Authors:  Sittisak Honsawek; Kesmanee Praianantathavorn; Voranush Chongsrisawat; Paisarn Vejchapipat; Apiradee Theamboonlers; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2010-12-30       Impact factor: 1.827

2.  Diagnostic values of plasma matrix metalloproteinase-7, interleukin-8, and gamma-glutamyl transferase in biliary atresia.

Authors:  Bo Wu; Ying Zhou; Xinbei Tian; Wei Cai; Yongtao Xiao
Journal:  Eur J Pediatr       Date:  2022-09-12       Impact factor: 3.860

3.  Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease.

Authors:  Kazuhiko Bessho; Reena Mourya; Pranavkumar Shivakumar; Stephanie Walters; John C Magee; Marepalli Rao; Anil G Jegga; Jorge A Bezerra
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

4.  Cholangiocyte secretion of chemokines in experimental biliary atresia.

Authors:  Mubeen Jafri; Bryan Donnelly; Alex Bondoc; Steven Allen; Greg Tiao
Journal:  J Pediatr Surg       Date:  2009-03       Impact factor: 2.545

5.  Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy.

Authors:  Sehee Kim; Jeffrey Moore; Estella Alonso; Joseph Bednarek; Jorge A Bezerra; Catherine Goodhue; Saul J Karpen; Kathleen M Loomes; John C Magee; Vicky L Ng; Averell H Sherker; Caroline Smith; Cathie Spino; Veena Venkat; Kasper Wang; Ronald J Sokol; Cara L Mack
Journal:  Hepatol Commun       Date:  2019-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.